Clin2
NCT03523221Possibly a fitRecruiting

Dexamethasone to prevent a second anaphylaxis reaction

Anaphylaxis

Treatments studied

Part of Immune system & allergy clinical trials.

This trial tests whether a dose of dexamethasone (a steroid medicine) can help stop anaphylaxis symptoms from returning after the first episode. It focuses on children with mild to moderate anaphylaxis in the emergency department.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
210 people
Ages
3 months to 14 years
Study type
Interventional

Who can take part

  • Be between 3 months and 14 years old
  • Be in the pediatric emergency department with mild to moderate anaphylaxis
  • Not have severe anaphylaxis
  • Not have a history of immune (immunologic) problems
  • Not be taking steroid medicines now
  • Not have moderate-to-severe asthma or severe asthma

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07341776Recruiting· Phase 4
Testing steroids for food allergy reactions

This trial tests whether using a steroid drug can help treat allergic reactions to food. If you have a food allergy that causes immediate symptoms (like hives or trouble breathing), this study may help find better ways to manage those reactions.

Basel, Basel
NCT07038746Recruiting· Phase 1
Inhaled epinephrine for severe allergic reactions during tests or treatment

This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.

Richmond, British Columbia
NCT05210543Recruiting
Study people after a severe allergic reaction

This trial follows people who have had anaphylaxis (a severe, life-threatening allergic reaction) within the last year. The goal is to better understand what happens over time so doctors can improve care.

Berlin
NCT07402707Recruiting· Phase 4
Dexamethasone for acute asthma in children

This trial tests if a different steroid (dexamethasone) is as good as the usual steroid for treating children with asthma attacks in the Emergency Department. It aims to make treatment easier for children.

Sheffield
NCT07455396Recruiting· Phase 2
Dexamethasone vs methylprednisolone for children with severe asthma

This trial compares two steroids, dexamethasone and methylprednisolone, to see which works better for children in the intensive care unit with severe asthma. The goal is to find the best treatment with fewer side effects.

St. Petersburg, Florida
NCT07228052Recruiting· Phase 4
Steroid shot to prevent return to the ER for asthma

This trial tests whether a single steroid shot given in the emergency department can help prevent your asthma symptoms from coming back and keep you from needing to return to the ER.

The Bronx, New York

Hear when a new Anaphylaxis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.